Usefulness of medial temporal lobe atrophy visual rating scale in detecting Alzheimer's disease: Preliminary study

Jae-Hyeok Heo1, Min-Ky Kim, Jun-Hyung Lee

  • 1Department of Neurology, Seoul Medical Center 156, Shinnae-dong, Chungrang-gu, Seoul, Korea.

Abstract

Insights

Combining cognitive tests with medial temporal atrophy (MTA) visual rating scales (VRS) may improve Alzheimer's disease (AD) screening. While the fused scores showed high accuracy, this study found no significant difference compared to cognitive tests alone, possibly due to small sample size.

Area of Science:

  • Neurology
  • Neuroimaging
  • Cognitive Science

Background:

  • Korean versions of Mini-Mental Status Examination (K-MMSE) and Addenbrooke Cognitive Examination (K-ACE) are validated dementia screening tools.
  • Medial temporal atrophy (MTA) is an early indicator of Alzheimer's disease (AD) pathology.

Purpose of the Study:

  • To evaluate the diagnostic validity of combining neuropsychological tests (K-MMSE, K-ACE) with a visual rating scale (VRS) for MTA in AD screening.
  • To assess if this fusion approach improves upon using cognitive tests alone.

Main Methods:

  • Fifty subjects (25 AD, 25 controls) underwent K-MMSE and K-ACE.
  • T1 axial imaging was used for VRS assessment of MTA.
  • Fusion scores were calculated by subtracting VRS from cognitive test scores.
  • Receiver operating characteristic (ROC) curves analyzed diagnostic performance.

Main Results:

  • K-MMSE, K-ACE, and VRS scores were significantly lower in the AD group.
  • Fusion of K-ACE with VRS showed high diagnostic accuracy (AUC 0.884, sensitivity 80%, specificity 88%).
  • Fusion scores demonstrated comparable or superior sensitivity and specificity compared to individual cognitive tests.

Conclusions:

  • The fusion of K-ACE and MTA VRS shows potential clinical utility for AD screening.
  • While promising, the study did not find a statistically significant superiority over cognitive tests alone, possibly due to sample size limitations.